30 May 2026

Last updated: Friday 29 May 2026

Research Directory

Swiss companies weather the turmoil in 2022

Capturing the promise of p38 MAPK inhibition

Destiny Pharma advances strategy against bacteria

HIV vaccine remains elusive but antivirals deliver value

FDA guides on accelerated approvals in oncology

Stock values decline and companies restructure

Adrenomed prepares global study in septic shock

Oncology pipeline marked by multiple therapy types

Targeting skeletal muscle to treat type 2 diabetes

After three years of Covid, risks to health remain